Francesca Pegoraro

Dr. Francesca Pegoraro

University of Naples Federico II, Naples, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Surgical Oncology
Verified
Journal Article
Closed access
RTRoberto Ivan Troisi
Roberto Ivan Troisi
FPFrancesca Pegoraro
Francesca Pegoraro
MGMariano Cesare Giglio
Mariano Cesare Giglio
GRGianluca Rompianesi
Gianluca Rompianesi
GBGiammauro Berardi
Giammauro Berardi
GPGiovanni Domenico De Palma
Giovanni Domenico De Palma

3 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
AMAntonio Mimmo
Antonio Mimmo
FPFrancesca Pegoraro
Francesca Pegoraro
RRRami Rhaiem
Rami Rhaiem
RMRoberto Montalti
Roberto Montalti
ADAlix Donadieu
Alix Donadieu
TPTullio Piardi
Tullio Piardi
(1) Background: colorectal liver metastases (CRLM) are the most common extra-lymphatic metastases in colorectal cancer; however, few patients are fit for curative surgery. Microwave ablation (MWA) showed promising outcomes in this cohort of patients. This systematic review and pooled analysis aimed to analyze the oncological results of MWA for CRLM. (2) Methods: Following PRISMA guidelines, PubMed, Scopus, EMBASE, Google Scholar, Science Direct, and the Wiley Online Library databases were searched for reports published before January 2021. We included papers assessing MWA, treating resectable CRLM with curative intention. We evaluated the reported MWA-related complications and oncological outcomes as being recurrence-free (RF), free from local recurrence (FFLR), and overall survival rates (OS). (3) Results: Twelve out of 4822 papers (395 patients) were finally included. Global RF rates at 1, 3, and 5 years were 65.1%, 44.6%, and 34.3%, respectively. Global FFLR rates at 3, 6, and 12 months were 96.3%, 89.6%, and 83.7%, respectively. Global OS at 1, 3, and 5 years were 86.7%, 59.6%, and 44.8%, respectively. A better FFLR was reached using the MWA surgical approach at 3, 6, and 12 months, with reported rates of 97.1%, 92.7%, and 88.6%, respectively. (4) Conclusions: Surgical MWA treatment for CRLM smaller than 3 cm is a safe and valid option. This approach can be safely included for selected patients in the curative intent approaches to treating CRLM.

20 April 2023 in HPB
Verified
Journal Article
Closed access
RMRoberto Montalti
Roberto Montalti
GRGianluca Rompianesi
Gianluca Rompianesi
GCGianluca Cassese
Gianluca Cassese
FPFrancesca Pegoraro
Francesca Pegoraro
MGMariano C. Giglio
Mariano C. Giglio
RTRoberto Ivan Troisi
Roberto Ivan Troisi

3 October 2022 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Open access
GPGiuseppe Palomba
Giuseppe Palomba
VDVincenza Paola Dinuzzi
Vincenza Paola Dinuzzi
FPFrancesca Pegoraro
Francesca Pegoraro
RTRoberto Ivan Troisi
Roberto Ivan Troisi
RMRoberto Montalti
Roberto Montalti
GAGiovanni Aprea
Giovanni Aprea
Background: Laparoscopic adrenalectomy (LA) is considered the “gold standard” treatment of adrenal lesions that are often coincidentally diagnosed during the radiologic workup of other diseases. This study aims to evaluate the intraoperative role of indocyanine green (ICG) fluorescence associated with preoperative 3-dimensional reconstruction (3DR) in laparoscopic adrenalectomy in terms of perioperative outcomes. To our knowledge, this is the first prospective case-controlled report comparing these techniques. Materials and Methods: All consecutive patients aged≥18 and undergoing laparoscopic transperitoneal adrenalectomy for all adrenal masses from January 1, 2019 to January 31, 2022 were prospectively enrolled. Patients undertaking standard LA and those undergoing preoperative 3D reconstruction and intraoperative ICG fluorescence were matched through a one-on-one propensity score matching analysis (PSM) for age, gender, BMI, CCI score, ASA score, lesion histology, tumor side, and lesion diameter. Differences in operative time, blood loss, intraoperative and postoperative complications, conversion rate, and length of stay were analyzed. Results: After propensity score matching analysis, we obtained a cohort of 36 patients divided into 2 groups of 18 patients each. The operative time and intraoperative blood loss were shorter in patients of the 3DR group (P=0,004 and P=0,004, respectively). There was no difference in terms of length of stay, conversion rate, and intraoperative and postoperative complications between the 2 groups. Conclusions: The use of intraoperative ICG in LA and preoperative planning with 3DR images is a safe and useful addition to surgery. Furthermore, we observed a reduction in terms of operating time and intraoperative blood loss.

15 November 2022 in Research Square
Verified
Preprint
Open access
PDF file
FPFrancesca Pegoraro
Francesca Pegoraro
SDSantangelo Domenico
Santangelo Domenico
SASantangelo Alfonso
Santangelo Alfonso
LPLuigi Pelosio
Luigi Pelosio
AJAkbar Jamshidi
Akbar Jamshidi
MSMichele Santangelo
Michele Santangelo
Background: Retroperitoneal sarcomas (RPS) are rare findings that can grow into large masses without eliciting severe symptoms. Nowadays surgical resection is the only radical therapy, whenever possible. We present two consecutive cases of RPSs that resulted in dedifferentiated liposarcomas (DDLPS) and underwent R0 surgical resection with and without a nephron-sparing procedure. The diagnostic workup, the surgical approach, the impact of late surgical management due to the COVID pandemic, and the latest literature on the topic will be discussed and analyzed. Case Presentation: The patients, who refused to undergo any medical examination during the prior two years due to the COVID pandemic, were admitted to our Institution complaining about weight loss and general abdominal discomfort. In the first case, we observed a primitive giant abdominal right neoplasm of retroperitoneal origin enveloping and medializing the right kidney. The second patient had a similar primitive retroperitoneal giant left neoplasm which didn’t affect the kidney. Given the masses’ characteristics and the absence of distant metastases, after a multidisciplinary discussion, radical surgical removal was carried out for both patients. The lesions appeared well-defined from the surrounding tissues, and significantly compressed all the adjacent organs, without signs of infiltration. In the first patient, the right kidney was surrounded and undetachable from the tumor and it was removed en bloc with the mass. The second patient benefited from a nephron-sparing resection, thanks to the existence of a clear cleavage plane. The postoperative courses were uneventful. Both the histological examinations were oriented towards a DDLPS. And both patients were addressed with adjuvant chemotherapy. Conclusions: The treatment of giant RPS is still challenging and requires multidisciplinary treatment as well as, when possible, radical surgical removal. The lack of tissue infiltration and the avoidance of major organs’ excision or reconstruction (including the kidney) could lead to an easier postoperative course and a better prognosis. When possible, surgical management of recurrences or incompletely resected masses must be pursued. As the COVID pandemic caused limited medicalization of many population groups and delayed diagnosis of other oncologic diseases, an increased number of DDLPSs could be expected in the near future.

1 May 2019 in Laparoscopic Surgery
Verified
Journal Article
Closed access
PDF file
RMRoberto Montalti
Roberto Montalti
MGMariano Cesare Giglio
Mariano Cesare Giglio
FPFrancesca Pegoraro
Francesca Pegoraro
GPGiovanni Domenico De Palma
Giovanni Domenico De Palma
RTRoberto Ivan Troisi
Roberto Ivan Troisi
Which is the best approach for liver resections of postero-superior liver segments?